Literature DB >> 26721785

Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care.

G De Pascale1, M S Vallecoccia2, A Schiattarella3, V Di Gravio2, S L Cutuli2, G Bello2, L Montini2, M A Pennisi2, T Spanu4, C Zuppi3, S A Quraishi5, M Antonelli2.   

Abstract

A relationship between vitamin D status and mortality in patients in intensive care units (ICU) has been documented. The present study aims to describe the clinical profile and sepsis-related outcome of critically ill septic patients with extremely low (<7 ng/mL) vitamin D levels at ICU admission. We conducted an observational study in the ICU of a teaching hospital including all patients admitted with severe sepsis/septic shock and undergoing 25-hydroxyvitamin D (25(OH)D) testing within the first 24 hours from admission. We studied 107 patients over 12 months. At ICU admission vitamin D deficiency (≤20 ng/mL) was observed in 93.5% of the patients: 57 (53.3%) showed levels <7 ng/mL. As primary outcome, sepsis-related mortality rate was higher in patients with vitamin D levels <7 ng/mL (50.9% versus 26%). Multivariate regression analysis showed that vitamin D concentration <7 ng/mL on ICU admission (p 0.01) and higher mean SAPS II (p <0.01) score were independent predictors of sepsis-related mortality. Patients with very low vitamin D levels suffered higher rate of microbiologically confirmed infections but a lower percentage of microbiological eradication with respect to patients whose values were >7 ng/mL (80.7% versus 58%, p 0.02; 35.3% versus 68%; p 0.03, respectively). Post hoc analysis showed that, in the extremely low vitamin D group, the 52 patients with pneumonia showed a longer duration of mechanical ventilation (9 days (3.75-12.5 days) versus 4 days (2-9 days), p 0.04) and the 66 with septic shock needed vasopressor support for a longer period of time (7 days (4-10 days) versus 4 days (2-7.25 days), p 0.02). Our results suggest that in critical septic patients extremely low vitamin D levels on admission may be a major determinant of clinical outcome. Benefits of vitamin D replacement therapy in this population should be elucidated.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Critical care medicine; intensive care unit admission; nutrition; outcome; sepsis; vitamin D

Mesh:

Substances:

Year:  2015        PMID: 26721785     DOI: 10.1016/j.cmi.2015.12.015

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  Impact of high-dose vitamin D3 on plasma free 25-hydroxyvitamin D concentrations and antimicrobial peptides in critically ill mechanically ventilated adults.

Authors:  Jenny E Han; Jessica A Alvarez; Jennifer L Jones; Vin Tangpricha; Mona A Brown; Li Hao; Lou Ann S Brown; Greg S Martin; Thomas R Ziegler
Journal:  Nutrition       Date:  2017-02-27       Impact factor: 4.008

2.  Serum vitamin D concentrations in hospitalized critically ill dogs.

Authors:  Jared A Jaffey; Robert C Backus; Kaylyn M McDaniel; Amy E DeClue
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

3.  The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies.

Authors:  Yun-Fang Zhou; Bang-An Luo; Lu-Lu Qin
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

4.  Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis.

Authors:  Yuye Li; Shifang Ding
Journal:  BMC Infect Dis       Date:  2020-03-04       Impact factor: 3.090

5.  Effects of a single dose of vitamin D in septic children: a randomized, double-blinded, controlled trial.

Authors:  Yu Wang; Zhongwen Yang; Li Gao; Zhenfeng Cao; Qianhan Wang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

6.  Vitamin D in infectious complications in critically ill patients with or without COVID-19.

Authors:  Alice G Vassiliou; Edison Jahaj; Stylianos E Orfanos; Ioanna Dimopoulou; Anastasia Kotanidou
Journal:  Metabol Open       Date:  2021-07-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.